Hormone replacement therapy is associated with improved cognition and larger brain volumes in at-risk APOE4 women: results from the European Prevention of Alzheimer's Disease (EPAD) cohort. (2023)

First Author: Saleh RNM

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s13195-022-01121-5

PubMed Identifier: 36624497

Publication URI: http://europepmc.org/abstract/MED/36624497

Type: Journal Article/Review

Volume: 15

Parent Publication: Alzheimer's research & therapy

Issue: 1